Premium
Applied Therapeutics Inc (APLT)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic expos... Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart. Show more
- NDA and MAA for govorestat for treatment of Classic Galactosemia under FDA Priority Review and EMA review; PDUFA target action date of November 28, 2024, and EMA decision expected in Q1 2025...
NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated...
- Company completed Late-Cycle review meeting with FDA - FDA no longer intends to hold Advisory Committee meeting - FDA Review of NDA continues to proceed as planned with PDUFA target action...
NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.65 | -16.0194174757 | 10.3 | 10.6237 | 8.65 | 2161307 | 9.42702003 | CS |
| 4 | -0.31 | -3.45982142857 | 8.96 | 10.6237 | 8.35 | 1801835 | 9.24519224 | CS |
| 12 | 2.86 | 49.3955094991 | 5.79 | 10.6237 | 4.55 | 2747806 | 8.03754769 | CS |
| 26 | 4.52 | 109.443099274 | 4.13 | 10.6237 | 3.95 | 1909990 | 7.10410661 | CS |
| 52 | 6.72 | 348.186528497 | 1.93 | 10.6237 | 1.79 | 1752934 | 5.89657836 | CS |
| 156 | -5.17 | -37.4095513748 | 13.82 | 13.98 | 0.4995 | 860598 | 4.62016379 | CS |
| 260 | -6.3 | -42.1404682274 | 14.95 | 57.39 | 0.4995 | 573496 | 7.24807312 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
